DBV Technologies S.A.
NASDAQ:DBVTBiotechnology
Healthcare
$9.99 -0.95%
-$0.16 today
- Market cap
- $238.98M
- Beta
- -0.22
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.39
52W Low $8.50High $26.19
Volume 0.17M
Average 0.24M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$121.18M
FY 2025 · Annual
Investing Cash Flow
-$1.37M
FY 2025 · Annual
Financing Cash Flow
$276.18M
FY 2025 · Annual
+46949.7% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (97.81M) | (96.27M) | (72.73M) | (113.92M) | (146.95M) |
| Depreciation & Amortization | 8.38M | 13.16M | (14M) | (925K) | 3.19M |
| Deferred Income Tax | 184K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.12M | 5.03M | 6.02M | 4.62M | 5.39M |
| Change in Working Capital | (22.77M) | 22.32M | 953K | 5.75M | 1.34M |
| Accounts Receivables | 2.15M | 0 | 0 | 0 | 0 |
| Inventory | (16.18M) | 0 | 0 | 0 | (16.11M) |
| Accounts Payables | (7.56M) | 3.46M | 8.42M | 272K | 15.83M |
| Other Working Capital | (1.19M) | 18.86M | (7.47M) | 5.48M | 1.62M |
| Other Non-Cash Items | 656K | 66K | 99K | (3K) | 15.84M |
| Operating Cash Flow | (108.24M) | (55.7M) | (79.65M) | (104.47M) | (121.18M) |
| Capital Expenditures | (918K) | (754K) | (677K) | (2.34M) | (533.64K) |
| Acquisitions (Net) | 511.01K | 7.61K | 0 | 0 | 0 |
| Purchases of Investments | (119K) | (123K) | (285K) | 0 | 0 |
| Sales of Investments | (511.01K) | 770K | 154K | 0 | 0 |
| Other Investing Activities | 604K | (611) | (131K) | 1.58M | (829.34K) |
| Investing Cash Flow | (433K) | (100K) | (808K) | (757K) | (1.37M) |
| Debt Repayment | (582.92K) | (474K) | 0 | 0 | 0 |
| Common Stock Issued | 978K | 194.59M | 6.92M | 634K | 277.04M |
| Common Stock Repurchased | 0 | 0 | (154K) | (47K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (121.08K) | (20K) | 0 | 0 | (854.56K) |
| Financing Cash Flow | 274K | 194.1M | 6.77M | 587K | 276.18M |
| Effect of Forex Changes | (10.65M) | (6.5M) | 5.87M | (4.27M) | 8.08M |
| Net Change in Cash | (119.05M) | 131.9M | (67.83M) | (108.91M) | 161.71M |
| Free Cash Flow | (109.16M) | (56.45M) | (80.33M) | (106.82M) | (121.18M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$146.9M
+ D&A$3.2M
+ Stock-Based Comp$5.4M
+ Deferred Tax$0
+ Working Capital$1.3M
+ Other Non-Cash$15.8M
= Operating Cash Flow-$121.2M
- Capex-$533.6K
= Free Cash Flow-$121.2M
Analysis
FY2025 free cash flow is -$121.2M. FCF conversion is 82.5% of net income. Operating cash flow was -$121.2M, with capex of -$533.6K. The largest bridge item is Other Non-Cash at $15.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 12, 2026 | |
| 8-K | Current report | Oct 28, 2026 | |
| 10-Q | Quarterly report | Oct 28, 2026 | |
| 8-K | Current report | Sep 30, 2026 |
Does DBVT generate free cash flow?
DBV Technologies S.A. (DBVT) generated -$121.18M of free cash flow in fiscal 2025.
How much operating cash flow does DBVT produce?
Operating cash flow was -$121.18M, before capital expenditures of $533,642.00.
Continue the stock analysis
Jump to another research area for this company.